Biolife Solutions (BLFS) Price to Sales (2010 - 2026)

Biolife Solutions (BLFS) has reported Price to Sales for 17 consecutive years, with 48.5 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Sales rose 10.3% year-over-year to 48.5 in Q2 2026; TTM through Jun 2026 was 13.43, a 6.83% increase from a year earlier, with the FY2025 full-year figure at 12.11, down 25.74% from the prior year.
• Price to Sales was 48.5 for Q2 2026 at Biolife Solutions, up from 33.88 in the prior quarter.
• Over five years, Price to Sales peaked at 80.6 in Q4 2024 and troughed at 52.52 in Q4 2023.
• A 5-year average of 32.72 and a median of 38.74 in 2025 frame the typical range for Price to Sales.
• Across the five-year window, Price to Sales plunged 177.97% in 2023 and surged 253.48% in 2024, its largest moves.
• Over 5 years, Price to Sales stood at 18.89 in 2022, then sank by 177.97% to 52.52 in 2023, then surged by 253.48% to 80.6 in 2024, then retreated by 23.03% to 62.04 in 2025, then dropped by 21.83% to 48.5 in 2026.
• The last three Price to Sales figures came in at 48.5 (Q2 2026), 33.88 (Q1 2026), and 62.04 (Q4 2025), per Business Quant data.